Efficacy of RGn600 in Patients With Mild-to-moderate Alzheimer's Disease

This study tests whether a device called RGn600 — worn on the body — can help improve symptoms in people with mild-to-moderate Alzheimer's disease in France. **You may be eligible if...** - You are between 55 and 85 years old - You have been diagnosed with Alzheimer's disease (mild to moderate stage, with a memory test score between 10 and 26) - You have had recent blood tests and a brain scan (CT or MRI) within the past year - You have a caregiver who can assist you throughout the study - You are enrolled in the French national health insurance system - If you take Alzheimer's or psychiatric medications, your dose has been stable for at least 4 weeks **You may NOT be eligible if...** - You are a woman who has not gone through menopause - You currently take a disease-modifying Alzheimer's drug (such as Leqembi) - You live in a medical facility - You have had surgery near your head or abdomen in the last 3 months - You have a pacemaker or metal implants near your head or abdomen - You have epilepsy, psychosis, or a genetic form of Alzheimer's - You have a life-threatening illness or recent stroke Talk to your doctor to see if this trial is right for you.